Rosa Maria Diaz
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$2.3MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 16, 2019 | NIH | SBIR Phase II Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors | $950K | VYRIAD INC |
| Feb 28, 2019 | NIH | SBIR Phase II Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors | $108K | VYRIAD INC |
| Sep 20, 2018 | NIH | SBIR Phase II Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors | $179K | VYRIAD INC |
| Apr 13, 2018 | NIH | SBIR Phase II INTRAVESICAL ONCOLYTIC THERAPY FOR BLADDER CANCER | $925K | VYRIAD INC |
| Sep 20, 2017 | NIH | SBIR Phase II INTRAVESICAL ONCOLYTIC THERAPY FOR BLADDER CANCER | $157K | VYRIAD INC |
Peer ranks
Federal funding#843
Awards as PI#417
Patents#273
Companies
- VYRIAD INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.